Recombinant Human Aggrecan G1-G2 Exhibits Native Binding Properties and Substrate Specificity for Matrix Metalloproteinases and Aggrecanase

This publication has 56 references indexed in Scilit:

• Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
  Journal of Clinical Investigation, 1997
• Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent.
  Journal of Clinical Investigation, 1996
• VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis.
  Journal of Clinical Investigation, 1995
• The structure of aggrecan fragments in human synovial fluid. evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis
  Arthritis & Rheumatism, 1993
• N-terminal sequence of proteoglycan fragments isolated from medium of interleukin-1-treated articular-cartilage cultures. Putative site(s) of enzymic cleavage
  Biochemical Journal, 1992
• The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain.
  Journal of Clinical Investigation, 1992
• Mechanism of catabolism of aggrecan by articular cartilage
  Archives of Biochemistry and Biophysics, 1992
• Turnover of proteoglycans in articular-cartilage cultures. Characterization of proteoglycans released into the medium
  Biochemical Journal, 1989
• The immunologic detection and characterization of cartilage proteoglycan degradation products in synovial fluids of patients with arthritis
  Arthritis & Rheumatism, 1987
• Articular cartilage cultured with interleukin 1. Increased release of link protein, hyaluronate-binding region and other proteoglycan fragments
  Biochemical Journal, 1986